Clinical Trial Update: Evaluating an Endocrine Therapy Dose-frequency Escalation Strategy and Its Effects on Tolerability and Compliance [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update describes evaluating a dose-frequency escalation strategy for an endocrine therapy in breast cancer and its effects on tolerabil…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Breast Cancer | Phase 4 | Status: ACTIVE_NOT_RECRUITING